These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16865687)

  • 1. Nutritional support for patients suffering from intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Imataki O; Nakatani S; Hasegawa T; Kondo M; Ichihashi K; Araki M; Ishida T; Kim SW; Mori S; Fukuda T; Tobinai K; Tanosaki R; Makimoto A; Takaue Y
    Am J Hematol; 2006 Oct; 81(10):747-52. PubMed ID: 16865687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
    Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
    Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
    Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease.
    Mattsson J; Westin S; Edlund S; Remberger M
    Bone Marrow Transplant; 2006 Nov; 38(9):629-33. PubMed ID: 16964269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Wakui M; Okamoto S; Ishida A; Kobayashi H; Watanabe R; Yajima T; Iwao Y; Hisamatsu T; Hibi T; Ikeda Y
    Bone Marrow Transplant; 1999 Mar; 23(6):573-8. PubMed ID: 10217188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonoscopy in the diagnosis of intestinal graft versus host disease and cytomegalovirus enteritis following allogeneic haematopoietic stem cell transplantation.
    He JD; Liu YL; Wang ZF; Liu DH; Chen H; Chen YH
    Chin Med J (Engl); 2008 Jul; 121(14):1285-9. PubMed ID: 18713549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition.
    Svahn BM; Remberger M; Heijbel M; Martell E; Wikström M; Eriksson B; Milovsavljevic R; Mattsson J; Ringdén O
    Transplantation; 2008 Apr; 85(7):1000-7. PubMed ID: 18408581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular graft-versus-host disease after allogeneic stem cell transplantation.
    Westeneng AC; Hettinga Y; Lokhorst H; Verdonck L; van Dorp S; Rothova A
    Cornea; 2010 Jul; 29(7):758-63. PubMed ID: 20489577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe intestinal graft versus host disease after donor lymphocyte infusion; response to extracorporeal photochemotherapy.
    Vural F; Donmez A; Doganavşargil B; Cagýrgan S; Alper H; Tombuloglu M
    Transfus Apher Sci; 2005 Oct; 33(2):129-33. PubMed ID: 16150645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease.
    Neumann S; Schoppmeyer K; Lange T; Wiedmann M; Golsong J; Tannapfel A; Mossner J; Niederwieser D; Caca K
    Gastrointest Endosc; 2007 Mar; 65(3):403-9. PubMed ID: 17321239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe acute gastrointestinal graft-vs-host disease: an emerging surgical dilemma in contemporary cancer care.
    Irani JL; Cutler CS; Whang EE; Clancy TE; Russell S; Swanson RS; Ashley SW; Zinner MJ; Raut CP
    Arch Surg; 2008 Nov; 143(11):1041-5; discussion 1046. PubMed ID: 19015460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
    Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of colonoscopy in patients with intestinal graft-versus-host disease after hematopoietic stem cell transplantation.
    Oomori S; Takagi S; Kikuchi T; Utsunomiya K; Yokoyama H; Negoro K; Tohmiya Y; Aihara H; Yamada M; Takahashi S; Kameoka J; Kinouchi Y; Shimosegawa T
    Endoscopy; 2005 Apr; 37(4):346-50. PubMed ID: 15824945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.